Immunogenic peptides of foot-and-mouth disease viruses

Details Immunogenic peptides of foot-and-mouth disease viruses Immunogenic peptides of foot-and-mouth disease viruses

2006-01-10

2006-01-10

Winkler, Ulrike (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S186100, C530S300000, C530S327000

Reexamination Certificate

active

06984387

ABSTRACT:
The present invention relates to FMDC vaccine based on peptides having a sequence of at least 8 amino acids, which corresponds to a partial sequence of the non-structural protein region of FMDV, which was selected by immunoreactivity with FMDV-specific antibodies or by immunoreactivity with FMDV-specific T lymphocytes, and to their production and their use.

REFERENCES:
patent: 4605512 (1986-08-01), Schaller et al.
patent: 5639601 (1997-06-01), Saeki et al.
patent: 6048538 (2000-04-01), Yi Wang et al.
Zamorano et al., “A 10-amino-acid linear sequence of VP1 of foot and mouth disease viruses containing B- and T-Cell epitopes induces protection in mice.” Virology vol. 212 (1995), p. 614-621.
Rodriguez et al., “Immunogenicity of non-structural proteins of foot and mouth disease virus: differences beween infected and vaccinated swine.” Archives of Virology vol. 136 (1994), p. 123-131.
Lubroth et al., “Absence of protein 2c from clarified foot and mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals.” Vaccine vol. 14 (1996), p. 410-427.
Morgan et al., “Protection of cattle and swine against foot and mouth disease, using biosynthetic peptide vaccines.” American Journal of Vetrinary Research vol. 51 (1990), p. 40-45.
Francis et al., “Immune response to uncoupled peptides of foot and mouth disease virus.” Immunology vol. 61 (1987), p. 1-6.
Zamorano et al., “Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.” Virology vol. 201 (1994) p. 383-387.
Van Lierop et al. The influence of MHC polymorphysim on the selection of T-cell determinants of FMDV in cattle. Immunology. vol. 84 (1995) pp. 79-85.
Gene Bank Accession #P03308.
J. Immunol., vol. 138, Mar. 15, 1987, Saalmüller et al, pp. 1852-1857, Monoclonal Antibodies Reactive With Swine Lymphocytes II. Detection of an Antigen on Resting T Cells Down-Regulated after Activation.
Immunobiol., vol. 190, (month unavailable) 1994, Saalmüller et al, pp. 23-34, Major Histocompatibility Antigen Class II Expressing Resting Porcine T Lymphocytes are Potent Antigen-Presenting Cells in Mixed Leukocyte Culture.
Immunology, vol. 81, (month unavailable) 1994, Saalmüller et al, pp. 578-583, Discrimination between two subsets of porcine CD8+ cytolytic T lymphocytes by the expression of CD5 antigen.
Journal of Gen. Virology, vol. 76, (month unavailable) 1995, pp. 3039-3049, Pauly et al Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope.
Cell. Immunol., vol. 168, (month unavailable) 1996, Summerfield et al, Functional Characterization Of Porcine CD4+CD8+ Extrathymic T Lymphocytes, pp. 291-296.
Immunology, vol. 88, (month unavailable) 1996, pp. 238-246, Pauly et al, Differentiation between MHC-restricted and non-MHC restricted porcine cytolytic T lymphocytes.

Affiliated with

Also associated with

Rating

Immunogenic peptides of foot-and-mouth disease viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic peptides of foot-and-mouth disease viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic peptides of foot-and-mouth disease viruses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3540123